PubMed Health⌕ Search

Biomedical subjects

F Teodori

Publications and source records attributed to F Teodori.

5 recordsLinked to original sources
PubMed2005

GENII-LIN: a new object-oriented interface for the GENII code.

GENII-LIN is a new object-oriented interface for GENII, a well-known analysis tool for the health impact evaluation of accidental or chronic release of radionuclides to the environment. GENII-LIN has been developed under the Linux OS, chosen because it is a stable, reliable and open source. The suite codes that constitute the original GENII simulation kernel have been re-implemented and built, using the G77, the Fortran 77 module of the GCC collection. The code modules and the flow of data among them are at present fully controlled by a management interface written in C++, which is the core of the package. GENII-LIN comes with a new graphical user interface (GUI), built using the QT libraries by Trolltech. Through the wizard-like GUI, the user has full control over the code and can easily handle both the input and the output files.

Body Burden↗
PubMed1986

Evaluation of the immunostimulating activity of erythromycin in man.

The effects of erythromycin on the immune system have been studied in healthy volunteers and patients suffering from chronic bronchopneumonial diseases, by means of the following assays: phagocytosis, natural killer activity and superoxide anion production. The tests were performed before and after oral administration of 1 g of erythromycin. The findings suggest that erythromycin enhances phagocytosis by means of increasing ingestion of microorganisms, superoxide anion (O2-) production as well as natural killer activity. Under the experimental conditions described these effects appear 4-6 h after drug intake and reach their maximum around the 8th hour.

Adult↗
PubMed1985

Penetration of erythromycin into tonsillar tissue.

A study was carried out to investigate serum levels and tonsillar tissue penetration of erythromycin in 80 children suffering from chronic tonsillitis who had to undergo tonsillectomy. Oral erythromycin ethyl succinate (1 g twice daily) was given for the 2 days preceding surgery, the last dose scheduled for 2, 3, 4 or 6 hours before the start of the operation and the withdrawal of blood and tissue samples. The results showed that erythromycin penetrated quickly into tonsillar tissue and the levels were higher in tissue than in serum at all time points. Mean levels of erythromycin were consistently greater than the minimum inhibitory concentrations for most common Gram-positive oro-pharyngeal pathogens and H. influenzae.

Administration, Oral↗